ProQR Therapeutics N.V. (PRQR) Insider Trading
Sector: Biotechnology · Market Cap: $267M · 0 insider purchases in the last 7 days
No open market insider purchases at ProQR Therapeutics N.V. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track PRQR on your watchlist.
Start for FreeAbout ProQR Therapeutics N.V. Insider Trading
2 insiders at ProQR Therapeutics N.V. (PRQR) have purchased stock in the past 90 days, totaling $757K across 3 transactions (450,000 shares).
The most recent purchase was by Director Filius Bart on July 17, 2026 — a $258K buy of 150,000 shares at $1.72, bringing his total holdings to 300,000 shares.
Insiders who purchased: de Boer Daniel Anton (CEO, 2 buys totaling $500K); Filius Bart (Director, 1 buy totaling $258K).
This insider buying is notable given that PRQR had no recorded open market purchases in the nine months before that.
PRQR is in the Biotechnology sector within the Biotechnology industry with a market cap of $267M.
Track PRQR insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.